This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. 2009-11-20 18:00 ET - News Release NEW YORK, Nov. 20, 2009 (GLOBE NEWSWIRE) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Hemispherx Biopharma, Inc. ("Hemispherx" or the "Company") (AMEX:HEB) stock during the period between February 18, 2009 and October 30, 2009, inclusive (the "Class Period") for violations of the federal securities laws.
No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased Hemispherx common stock during the Class Period, and wish to move the court for appointment of lead plaintiff, you must do so by January 11, 2010. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period. You do not need to seek appointment as a lead plaintiff in order to share in any recovery.
The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page